This study has three key findings. First, although metformin use has increased in the past decade for treatment of the general population with type 2 diabetes, it remains underused among individuals ...

September 21, 2012 — Metformin was associated with a lower risk for cardiovascular disease, all-cause mortality, and serious infection/acidosis compared with insulin in a large database analysis of ...

The patient is a 63-year-old man who has had type 2 diabetes for 20 years. He was admitted to the hospital to undergo right robotic partial nephrectomy and has a history of renal mass. One year prior ...

This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice. Conclusions: ...

NEW YORK, Aug. 25 (UPI) --Medical science continues to develop new and innovative ways to boost health and well-being, but a relatively old drug -- metformin -- may hold the key to human longevity and ...

Overall survival in men with metastatic castration-resistant prostate cancer treated with olaparib or lutetium-177-PSMA-617 following prior systemic therapy. Carboplatin in patients with metastatic ...